Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven
pharmaceutical company, and Galderma, a global healthcare company
focused on dermatology and skin health, today announced that they have
significantly expanded the scope of their neurotoxin partnership.
for Ipsen and Galderma become exclusive partners for development and marketing of neurotoxins in the US, Canada, Brazil and Europe1 investment picks